Table 2.
Use of the G-CSF guidelines in the daily work of pharmacists
| n = 301 | |
|---|---|
| Q6. What do you use as a reference for the use of G-CSFs in clinical practice?(multiple choice) | |
| Clinical practice guideline | 292 (97.0)a |
| Guideline of ASCO | 101 (33.6) |
| Guideline of ERTC | 11 (3.7) |
| Guideline of NCCN | 95 (31.6) |
| Package insert | 191 (63.5) |
| Q7. How much importance do you give to the guideline for the use of G-CSFs in clinical practice? | |
| A high level of importance | 92 (30.6) |
| Give some importance | 187 (62.1) |
| Do not give importance much | 22 (7.3) |
| Do not give importance at all | 0 (0.0) |
| Q8. Do you use the Japanese or foreign guidelines? | |
| Japanese guidelines | 229 (76.0) |
| Foreign guidelines | 3 (1.0) |
| Japanese and foreign guidelines | 67 (22.3) |
| Neither | 2 (0.7) |
G-CSF Granulocyte-Colony Stimulating Factor, NCCN National Comprehensive Cancer Network, EORTC European Organisation for Research and Treatment of Cancer, ASCO American Society of Clinical Oncology
aNumber (percent)